This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
As if there weren’t already enough Achieve TMS locations all over the United States, especially in Massachusetts now one more is added to the list. Achieve TMS now has 14 locations across the United States and still stands as BrainsWay’s largest clientele provider.